1h Free Analyst Time
The protein therapeutics market is forecast to grow by USD 172.8 billion during 2023-2028, accelerating at a CAGR of 9.47% during the forecast period. The report on the protein therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased demand for MABS, development of novel therapies using innovative technologies, and availability of favorable reimbursement policies.
The protein therapeutics market is segmented as below:
By Product
- mAbs
- Human insulin
- Erythropoeitin
- Clotting factors
- Others
By Application
- Metabolic disorders
- Immunologic disorders
- Hematological disorders
- Cancer
- Genetic disorders
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the protein therapeutics market covers the following areas:
- Protein therapeutics market sizing
- Protein therapeutics market forecast
- Protein therapeutics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global protein therapeutics market: AbbVie Inc., Amgen Inc., AstraZeneca Plc, Biocon Ltd., Biogen Inc., Bristol Myers Squibb Co., Celltrion Healthcare Co. Ltd., Creative Biolabs, Eli Lilly and Co., F. Hoffmann La Roche Ltd., Intas Pharmaceuticals Ltd., Ipsen Pharma, Johnson and Johnson Services Inc., LGM Pharma LLC, Midas Pharma GmbH, Novartis AG, Novo Nordisk AS, Pfizer Inc., PV Pharma Healthcare Pvt. Ltd., and Sanofi SA.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is continued focus on improvement of protein therapeutics."
According to the report, one of the major drivers for this market is the increased demand for mAbs.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Amgen Inc.
- AstraZeneca Plc
- Biocon Ltd.
- Biogen Inc.
- Bristol Myers Squibb Co.
- Celltrion Healthcare Co. Ltd.
- Creative Biolabs
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- Intas Pharmaceuticals Ltd.
- Ipsen Pharma
- Johnson and Johnson Services Inc.
- LGM Pharma LLC
- Midas Pharma GmbH
- Novartis AG
- Novo Nordisk AS
- Pfizer Inc.
- PV Pharma Healthcare Pvt. Ltd.
- Sanofi SA
